MENU
+Compare
BINP
Stock ticker: OTC
AS OF
Oct 17 closing price
Price
$0.04
Change
+$0.01 (+33.33%)
Capitalization
2.05M

BINP stock forecast, quote, news & analysis

Bionoid Pharma Inc is a technology-focused company developing proprietary software solutions that leverage artificial intelligence (AI) and automation to optimize customer acquisition and audience engagement... Show more

BINP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for BINP with price predictions
Oct 17, 2025

BINP in +52.00% Uptrend, rising for three consecutive days on October 17, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BINP advanced for three days, in of 34 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 06, 2025. You may want to consider a long position or call options on BINP as a result. In of 48 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BINP just turned positive on October 07, 2025. Looking at past instances where BINP's MACD turned positive, the stock continued to rise in of 29 cases over the following month. The odds of a continued upward trend are .

BINP moved above its 50-day moving average on October 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BINP crossed bullishly above the 50-day moving average on October 17, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BINP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BINP broke above its upper Bollinger Band on October 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BINP entered a downward trend on October 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (61.544). P/E Ratio (0.000) is within average values for comparable stocks, (37.720). BINP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.699). BINP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.000) is also within normal values, averaging (79.813).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BINP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BINP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.65B. The market cap for tickers in the group ranges from 1.86K to 223.72B. ABT holds the highest valuation in this group at 223.72B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 1%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 19%. KLYG experienced the highest price growth at 68%, while WOK experienced the biggest fall at -49%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -24%. For the same stocks of the Industry, the average monthly volume growth was 8% and the average quarterly volume growth was -15%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 76
Price Growth Rating: 59
SMR Rating: 88
Profit Risk Rating: 92
Seasonality Score: 12 (-100 ... +100)
View a ticker or compare two or three
BINP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
433 N Camden Dr
Phone
+1 800 784-7641
Employees
2
Web
https://www.bionoidpharma.com